| Sign In to gain access to subscriptions and/or personal tools. |
Gingival Hyperplasia in Dogs Induced by Oxodipine, a Calcium Channel Blocking AgentLife Science Research Israel, Ness Ziona, Israel
Life Science Research Israel, Ness Ziona, Israel
Department of Orthopedic Surgery, Soroka Medical Center, Be'er Sheva, Israel
Life Science Research Israel, Ness Ziona, Israel
Department of Oral Pathology, Hadassah University Hospital, Jerusalem, Israel
Instituto Quimico Biologico, Madrid, Spain Subchronic oral exposure of dogs to Oxodipine, a new calcium channel blocker of the dihydropyridine-type, resulted in dose-related gingival hyperplastic changes. The doses at which an effect was elicited were 24 and 73 times the intended therapeutic dose for man. The effeçts were first noted after 7 weeks of treatment, and were limited to the high and intermediate dose groups of both sexes. Macroscopically, a generalized enlargement of the maxillary and mandibular facial and lingual gingivae were noted. The histological changes were similar to those described in man for Nifedipine and hydantoin-related drugs. An increase in the activity of alkaline phosphatase and a decrease in alanine aminotransferase was demonstrated. This article is the first to describe gingival hyperplasia in dogs induced in a dose-dependent manner by a calcium channel blocker.
Toxicologic Pathology, Vol. 16, No. 3,
327-332 (1988) |
|
|||

